Abstract
The purposes of this study were to determine the tumor necrosis factor (TNF) and interleukin-6 (IL-6) levels after the induction of acute necrotizing pancreatitis, and to establish the effects of pentoxifylline on cytokine production. Methods: acute pancreatitis was induced by the retrograde injection of 200 βl taurocholic acid into the pancreatic duct in male Wistar rats. The serum amylase activity, the wet pancreatic weight/body weight ratio, and the TNF and IL-6 levels were measured. Seven mg/kg pentoxifylline were administered intraperitoneally at the time of operation 6, 12 or 24 h later. Rats were killed 6, 24, 48 or 72 h after the operation. Results: the TNF bioassay revealed high levels of TNF (30.2±5.4 U/ml, 35.0±5.0 U/ml and 36.6±6.0 U/ml) in the control group at 6, 24 and 48 h and (54.1±20U/ml and 10.9±4.2 U/ml) in the pentoxifylline-treated group at 6 and 24 h, respectively, whereas the level had decreased to zero in the pentoxifylline-treated group at 48 h. The IL-6 bioassay likewise demonstrated high levels of IL-6 in the control group at 48 h and in the pentoxifylline-treated group at 6 and 24 h, and markedly decreased levels in the pentoxifylline-treated group at 48 h (7083±2844 pg/ml, 6463±1307 pg/ml, 10329±5571 pg/ml vs 137.5±85.5 pg/ml, respectively, P <0.05). The high mortality observed in the pancreatitis group (43%) was decreased by pentoxifylline administration to 11%. Conclusion: these results demonstrate that pentoxifylline very effectively inhibits cytokine production in acute pancreatitis.
Similar content being viewed by others
References
Aho HJ, Koskensalo SM-L, Nevalainen TJ (1980) Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol 15:411–416
Arden LA, de Groot ER, Shaap OL (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunology 17:1411–1416
Ceska M, Birath K, Brown B (1969) A new and rapid method for the clinical determination of amylase activities in human serum and urine. Clin Chem Acta 26:437–444
Doherty GM, Christian Jensen J, Alexander R, et al (1991) Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192–198
Espevik T, Niessen-Meyer JA (1986) A highly sensitive cell line WEHI 164 for measuring cytotoxic factor/tumor necrosis factor. J Immunol Methods 95:99–105
Exley AR, Leese T, Holliday MP (1992) Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut 33:1126–1128
Farkas Gy, Mandi Y, Marton J (1996) Modification of cytokine production in septic condition following necrotizing pancreatitis. In: Papastamatiou L (ed) European I. H. P. B. A. Congress Athens ’95. Monduzzi Editore, Bologna, pp 609–613
Grewal HP, Kotb M, Mohey El Din A (1994) Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 115:213–221
Gross V, Lese H-G, Heinisch A (1993) Inflammatory mediators and cytokines — new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepato-Gastroenterol 40:522–530
Heath DI, Cruickshank A, Gudgeon M (1993) Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34:41–45
Hughes CB, Grewal HP, Gaber LW (1996) Anti-TNF α therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 171:274–280
McKay C, Gallagher G, Baxter JN (1994) Systemic complications in acute pancreatitis are associated with increased monocyte cytokine release. Gut 35:A574–576
Norman JG, Franz M, Fink GS (1995) Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 221:625–634
Norman J, Franz M, Messina J (1995) Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117:648–655
Rinderknecht H (1994) Genetic determinants of mortality in acute necrotizing pancreatitis. Int J Pancreatol 16:11–15
Samlaska CP, Winfield EA (1994) Pentoxifylline (clinical review). J Am Acad Dermatol 30:603–621
Takacs T, Jr, Farkas G, Czako L, Jarmay K, Mandi Y, Lonovics J (1996) Time-course changes in serum cytokine levels in two experimental acute pancreatitis models in rats. Res ExpMed 196:153–161
Viedma JA, Perz-Mateo M, Dominguez JE (1992) Role of interleukin-6 in acute pancreatitis. Comparison wit C-reactive protein and phospholipase A. Gut 33:1264–1267
Windsor JA, Fearon KCH, Ross JA (1993) Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 80:1042–1046
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marton, J., Farkas, G., Takacs, T. et al. Beneficial effects of pentoxifylline treatment of experimental acute pancreatitis in rats. Res. Exp. Med. 197, 293–299 (1997). https://doi.org/10.1007/s004330050078
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004330050078